358 related articles for article (PubMed ID: 24418176)
21. A horsefly saliva antigen 5-like protein containing RTS motif is an angiogenesis inhibitor.
Ma D; Gao L; An S; Song Y; Wu J; Xu X; Lai R
Toxicon; 2010 Jan; 55(1):45-51. PubMed ID: 19635491
[TBL] [Abstract][Full Text] [Related]
22. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
[TBL] [Abstract][Full Text] [Related]
23. The alpha1beta1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization.
Gotwals PJ; Chi-Rosso G; Lindner V; Yang J; Ling L; Fawell SE; Koteliansky VE
J Clin Invest; 1996 Jun; 97(11):2469-77. PubMed ID: 8647938
[TBL] [Abstract][Full Text] [Related]
24. Structural determinants of the selectivity of KTS-disintegrins for the alpha1beta1 integrin.
Kisiel DG; Calvete JJ; Katzhendler J; Fertala A; Lazarovici P; Marcinkiewicz C
FEBS Lett; 2004 Nov; 577(3):478-82. PubMed ID: 15556632
[TBL] [Abstract][Full Text] [Related]
25. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis.
Olfa KZ; José L; Salma D; Amine B; Najet SA; Nicolas A; Maxime L; Raoudha Z; Kamel M; Jacques M; Jean-Marc S; Mohamed el A; Naziha M
Lab Invest; 2005 Dec; 85(12):1507-16. PubMed ID: 16200076
[TBL] [Abstract][Full Text] [Related]
26. KTS and RTS-disintegrins: anti-angiogenic viper venom peptides specifically targeting the alpha 1 beta 1 integrin.
Calvete JJ; Marcinkiewicz C; Sanz L
Curr Pharm Des; 2007; 13(28):2853-9. PubMed ID: 17979730
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor.
Nyberg P; Xie L; Sugimoto H; Colorado P; Sund M; Holthaus K; Sudhakar A; Salo T; Kalluri R
Exp Cell Res; 2008 Nov; 314(18):3292-305. PubMed ID: 18775695
[TBL] [Abstract][Full Text] [Related]
28. Rhinocetin, a venom-derived integrin-specific antagonist inhibits collagen-induced platelet and endothelial cell functions.
Vaiyapuri S; Hutchinson EG; Ali MS; Dannoura A; Stanley RG; Harrison RA; Bicknell AB; Gibbins JM
J Biol Chem; 2012 Jul; 287(31):26235-44. PubMed ID: 22689571
[TBL] [Abstract][Full Text] [Related]
29. Anti-angiogenic cues from vascular basement membrane collagen.
Colorado PC; Torre A; Kamphaus G; Maeshima Y; Hopfer H; Takahashi K; Volk R; Zamborsky ED; Herman S; Sarkar PK; Ericksen MB; Dhanabal M; Simons M; Post M; Kufe DW; Weichselbaum RR; Sukhatme VP; Kalluri R
Cancer Res; 2000 May; 60(9):2520-6. PubMed ID: 10811134
[TBL] [Abstract][Full Text] [Related]
30. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
Sudhakar A; Nyberg P; Keshamouni VG; Mannam AP; Li J; Sugimoto H; Cosgrove D; Kalluri R
J Clin Invest; 2005 Oct; 115(10):2801-10. PubMed ID: 16151532
[TBL] [Abstract][Full Text] [Related]
31. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
[TBL] [Abstract][Full Text] [Related]
32. Tea polyphenols inhibit rat vascular smooth muscle cell adhesion and migration on collagen and laminin via interference with cell-ECM interaction.
Lo HM; Hung CF; Huang YY; Wu WB
J Biomed Sci; 2007 Sep; 14(5):637-45. PubMed ID: 17436062
[TBL] [Abstract][Full Text] [Related]
33. Selectivity of the collagen-binding integrin inhibitors, TC-I-15 and obtustatin.
Hunter EJ; Hamaia SW; Gullberg D; Malcor JD; Farndale RW
Toxicol Appl Pharmacol; 2021 Oct; 428():115669. PubMed ID: 34363821
[TBL] [Abstract][Full Text] [Related]
34. CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis.
Ben-Mabrouk H; Zouari-Kessentini R; Montassar F; Koubaa ZA; Messaadi E; Guillonneau X; ElAyeb M; Srairi-Abid N; Luis J; Micheau O; Marrakchi N
Int J Biol Macromol; 2016 May; 86():670-80. PubMed ID: 26853827
[TBL] [Abstract][Full Text] [Related]
35. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
36. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
[TBL] [Abstract][Full Text] [Related]
37. Blocking of α1β1 and α2β1 adhesion molecules inhibits eosinophil migration through human lung microvascular endothelial cell monolayer.
Bazan-Socha S; Żuk J; Plutecka H; Jakieła B; Mlicka-Kowalczyk E; Krzyżanowski B; Marcinkiewicz C; Zaręba L; Bazan JG; Musiał J
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1444-51. PubMed ID: 25531708
[TBL] [Abstract][Full Text] [Related]
38. Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice.
Schapira K; Lutgens E; de Fougerolles A; Sprague A; Roemen A; Gardner H; Koteliansky V; Daemen M; Heeneman S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1917-24. PubMed ID: 15976328
[TBL] [Abstract][Full Text] [Related]
39. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
[TBL] [Abstract][Full Text] [Related]
40. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
